Cambridge Biomagnetics Ltd (CBM) is pleased to announce that a Patent covering the core of its technology has been granted by the US patent office. Armed with protection over the central aspects of its innovative solution, the company will speed up its efforts to build the necessary IP portfolio for protection in the various markets where CBM’s platform technoloby can be applied.